Literature DB >> 11745358

High IL-13 production by human neonatal T cells: neonate immune system regulator?

L M Ribeiro-do-Couto1, L C Boeije, J S Kroon, B Hooibrink, B S Breur-Vriesendorp, L A Aarden, C J Boog.   

Abstract

Neonates are highly susceptible to diseases and display biased type 2 immune responses, although no skewing to type 2 cytokines has been reported. In view of the emerging importance of IL-13 in type 2 inflammatory responses and clinical allergy, we analyzed IL-13 production by neonatal T cells. We found that, mainly CD8 T cells produced high levels of IL-13, while producing low levels of IL-4, IL-10 and IFN-gamma, upon primary and secondary stimulation. Our results point towards a possible immunoregulatory role of CD8 T cells in neonate responses. Moreover, they suggest that the abundance of IL-13 in the neonate immune system might account for the type 2 bias in neonates, providing a basis for the high disease susceptibility of newborns, for instance to allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745358     DOI: 10.1002/1521-4141(200111)31:11<3394::aid-immu3394>3.0.co;2-b

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Down-regulation of Th1 responses in human neonates.

Authors:  L Marodi
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population.

Authors:  Ilka Engelmann; Ulrike Moeller; Andrea Santamaria; Peter G Kremsner; Adrian J F Luty
Journal:  Immunology       Date:  2006-09-20       Impact factor: 7.397

3.  Heterogeneity in the CD4 T Cell Compartment and the Variability of Neonatal Immune Responsiveness.

Authors:  Becky Adkins
Journal:  Curr Immunol Rev       Date:  2007-08

Review 4.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

5.  Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life.

Authors:  Norah L Smith; Erin Wissink; Jocelyn Wang; Jennifer F Pinello; Miles P Davenport; Andrew Grimson; Brian D Rudd
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

6.  IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.

Authors:  Frank D Vladich; Susan M Brazille; Debra Stern; Michael L Peck; Raffaella Ghittoni; Donata Vercelli
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

7.  Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation.

Authors:  Melissa A Mazur; Craig C Davis; Paul Szabolcs
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

8.  NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells.

Authors:  Patricia Kiesler; Paul A Haynes; Lingfang Shi; Peter N Kao; Vicki H Wysocki; Donata Vercelli
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

Review 9.  Immune reconstitution after unrelated cord blood transplantation.

Authors:  P Szabolcs; D Niedzwiecki
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

10.  An allergy-associated polymorphism in a novel regulatory element enhances IL13 expression.

Authors:  Patricia Kiesler; Arvind Shakya; Dean Tantin; Donata Vercelli
Journal:  Hum Mol Genet       Date:  2009-08-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.